Eisai
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Launch date
Employees
Market cap
$12.7b
Enterprise valuation
$11.2b (Public information from Sep 2024)
Share price
JPY5805
Tokyo Japan (HQ)
Financials
Estimates*
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 4.5b | 5.3b | 5.2b | 5.2b | 5.4b | 5.9b | 6.2b |
| % growth | (7 %) | 17 % | (2 %) | - | 3 % | 9 % | 6 % |
| EBITDA | 616m | 645m | 560m | 650m | 673m | 765m | 809m |
| % EBITDA margin | 14 % | 12 % | 11 % | 13 % | 13 % | 13 % | 13 % |
| Profit | 295m | 336m | 388m | 297m | 314m | 426m | 465m |
| % profit margin | 7 % | 6 % | 7 % | 6 % | 6 % | 7 % | 7 % |
| EV / revenue | 3.0x | 1.9x | 2.7x | 2.2x | 2.0x | 1.8x | 1.7x |
| EV / EBITDA | 22.3x | 15.3x | 25.1x | 17.6x | 16.1x | 14.1x | 13.3x |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
$25.0m Valuation: $25.0m | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Eisai
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
